LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 35

Search options

  1. Article ; Online: En langsomtvoksende bakterie.

    Sjursen, Haakon

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

    2011  Volume 131, Issue 22, Page(s) 2249

    Title translation A slow growing bacteria.
    MeSH term(s) Abscess/microbiology ; Facial Dermatoses/microbiology ; Female ; Humans ; Nocardia Infections
    Language Norwegian
    Publishing date 2011-11-15
    Publishing country Norway
    Document type Comment ; Journal Article
    ZDB-ID 603504-8
    ISSN 0807-7096 ; 0029-2001
    ISSN (online) 0807-7096
    ISSN 0029-2001
    DOI 10.4045/tidsskr.11.0993
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Sjelden årsak til alvorlig lidelse.

    Sjursen, Haakon

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

    2010  Volume 130, Issue 2, Page(s) 152

    Title translation Rare cause of severe disease.
    MeSH term(s) Aggregatibacter actinomycetemcomitans ; Bacterial Typing Techniques ; Cardiobacterium ; Eikenella corrodens ; Endocarditis, Bacterial/diagnosis ; Endocarditis, Bacterial/drug therapy ; Endocarditis, Bacterial/microbiology ; Gram-Negative Bacterial Infections/diagnosis ; Gram-Negative Bacterial Infections/drug therapy ; Gram-Negative Bacterial Infections/microbiology ; Haemophilus parainfluenzae ; Humans ; Kingella kingae ; Molecular Diagnostic Techniques ; Periodontitis/microbiology
    Language Norwegian
    Publishing date 2010-01-28
    Publishing country Norway
    Document type Comment ; Journal Article
    ZDB-ID 603504-8
    ISSN 0807-7096 ; 0029-2001
    ISSN (online) 0807-7096
    ISSN 0029-2001
    DOI 10.4045/tidsskr.09.1536
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Reply to Drs. Karakonstantis and Kalemaki.

    Naess, Are / Eide, Geir Egil / Sjursen, Haakon

    Infection

    2017  

    Language English
    Publishing date 2017-09-01
    Publishing country Germany
    Document type Letter
    ZDB-ID 185104-4
    ISSN 1439-0973 ; 0300-8126 ; 0173-2129
    ISSN (online) 1439-0973
    ISSN 0300-8126 ; 0173-2129
    DOI 10.1007/s15010-017-1066-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Immune responses after live attenuated influenza vaccination.

    Mohn, Kristin G-I / Smith, Ingrid / Sjursen, Haakon / Cox, Rebecca Jane

    Human vaccines & immunotherapeutics

    2018  Volume 14, Issue 3, Page(s) 571–578

    Abstract: Since 2003 (US) and 2012 (Europe) the live attenuated influenza vaccine (LAIV) has been used as an alternative to the traditional inactivated influenza vaccines (IIV). The immune responses elicted by LAIV mimic natural infection and have been found to ... ...

    Abstract Since 2003 (US) and 2012 (Europe) the live attenuated influenza vaccine (LAIV) has been used as an alternative to the traditional inactivated influenza vaccines (IIV). The immune responses elicted by LAIV mimic natural infection and have been found to provide broader clinical protection in children compared to the IIVs. However, our knowledge of the detailed immunological mechanisims induced by LAIV remain to be fully elucidated, and despite 14 years on the global market, there exists no correlate of protection. Recently, matters are further complicated by differing efficacy data from the US and Europe which are not understood. Better understanding of the immune responses after LAIV may aid in achieving the ultimate goal of a future "universal influenza vaccine". In this review we aim to cover the current understanding of the immune responses induced after LAIV.
    MeSH term(s) Animals ; Antibodies, Viral/immunology ; Humans ; Influenza Vaccines/immunology ; Influenza, Human/immunology ; Influenza, Human/prevention & control ; Orthomyxoviridae Infections/immunology ; Vaccination/methods ; Vaccines, Attenuated/immunology ; Vaccines, Inactivated/immunology
    Chemical Substances Antibodies, Viral ; Influenza Vaccines ; Vaccines, Attenuated ; Vaccines, Inactivated
    Language English
    Publishing date 2018-01-03
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2664176-8
    ISSN 2164-554X ; 2164-5515
    ISSN (online) 2164-554X
    ISSN 2164-5515
    DOI 10.1080/21645515.2017.1377376
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A man with fever and joint pain.

    Lutro, Olav / Lillebø, Kristine / Schrama, Johannes Cornelis / Dale, Håvard / Sjursen, Haakon

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

    2016  Volume 136, Issue 23-24, Page(s) 1999–2001

    Title translation En mann med feber og leddsmerter.
    MeSH term(s) Aged ; Anti-Bacterial Agents/therapeutic use ; Arthralgia/microbiology ; Arthritis, Infectious/drug therapy ; Arthritis, Infectious/microbiology ; Fever/microbiology ; Gonorrhea/complications ; Gonorrhea/diagnosis ; Gonorrhea/drug therapy ; Gonorrhea/epidemiology ; Humans ; Male ; Middle Aged ; Neisseria gonorrhoeae/isolation & purification ; Norway/epidemiology ; Travel
    Chemical Substances Anti-Bacterial Agents
    Language Norwegian
    Publishing date 2016-12
    Publishing country Norway
    Document type Case Reports
    ZDB-ID 603504-8
    ISSN 0807-7096 ; 0029-2001
    ISSN (online) 0807-7096
    ISSN 0029-2001
    DOI 10.4045/tidsskr.16.0266
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Cardiac surgery for infective endocarditis in patients with intravenous drug use.

    Østerdal, Oda Bratland / Salminen, Pirjo-Riitta / Jordal, Stina / Sjursen, Haakon / Wendelbo, Øystein / Haaverstad, Rune

    Interactive cardiovascular and thoracic surgery

    2016  Volume 22, Issue 5, Page(s) 633–640

    Abstract: Objectives: Intravenous drug users have a high risk of infective endocarditis and reduced survival. Cardiac surgery may be recommended for these patients, but redo surgery is controversial. This study describes the characteristics and outcomes of ... ...

    Abstract Objectives: Intravenous drug users have a high risk of infective endocarditis and reduced survival. Cardiac surgery may be recommended for these patients, but redo surgery is controversial. This study describes the characteristics and outcomes of intravenous drug users accepted for surgery during a 12-year period.
    Methods: This retrospective study included 29 injecting drug users treated with valve surgery for endocarditis between January 2001 and December 2013 at a tertiary academic centre. Survival was assessed by Kaplan-Meier analysis.
    Results: The median patient age was 36 (24-63) years and 27 patients (93%) were male. Staphylococcus aureus (52%) and Enterococcus faecalis (17%) were the most common microorganisms. Common illicit drugs were opioids (69%), amphetamines (52%) and benzodiazepines (24%). Mixed abuse was reported in 66% of patients. Seven patients (24%) had prior intracardial implants or native valve pathology. Twenty-five patients (86%) were positive for hepatitis C virus antibody, but none carried the human immunodeficiency virus. Twelve (41%) were homeless and 15 (52%) had poor dental hygiene. Three patients (10%) received medication-assisted rehabilitation before surgery. The main indications for surgery were regurgitation and secondary heart failure (86%), embolization (41%) and uncontrolled infection (24%). Aortic valve replacement was performed in 24 patients (83%), either as part of univalvular or multiple valve surgery. Seven patients (24%) had multivalvular endocarditis. All but 3 patients received biological valve prostheses. The 30-day mortality was 7% after first time surgery. During follow-up, 15 patients (52%) presented with reinfection: 10 (35%) were offered a second and 2 (7%) a third operation. Thirty-day mortality was 10% after redo surgery. Thirteen patients (45%) died within a median of 22 (0-84) months. Continued intravenous drug use was reported in 70 and 44% of patients after the first and second operation, respectively.
    Conclusions: Cardiac surgery for infective endocarditis has acceptable early postoperative results among intravenous drug users. The 2- and 5-year survival were 79 and 59%, respectively. The number of reinfections was high within 2 years, as continued drug use seems to be a major challenge for this group.
    MeSH term(s) Adult ; Cardiac Surgical Procedures/methods ; Cardiac Surgical Procedures/mortality ; Endocarditis, Bacterial/etiology ; Endocarditis, Bacterial/surgery ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Norway/epidemiology ; Prognosis ; Retrospective Studies ; Staphylococcal Infections/etiology ; Staphylococcal Infections/mortality ; Staphylococcal Infections/surgery ; Staphylococcus aureus/isolation & purification ; Substance Abuse, Intravenous/complications ; Substance Abuse, Intravenous/mortality ; Survival Rate/trends ; Time Factors ; Young Adult
    Language English
    Publishing date 2016
    Publishing country England
    Document type Journal Article
    ZDB-ID 2095298-3
    ISSN 1569-9285 ; 1569-9293
    ISSN (online) 1569-9285
    ISSN 1569-9293
    DOI 10.1093/icvts/ivv397
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever.

    Naess, Are / Nilssen, Siri Saervold / Mo, Reidun / Eide, Geir Egil / Sjursen, Haakon

    Infection

    2016  Volume 45, Issue 3, Page(s) 299–307

    Abstract: Purpose: To study the role of the neutrophil:lymphocyte ratio (NLR) and monocyte:lymphocyte ratio (MLR) in discriminating between different patient groups hospitalized for fever due to infection and those without infection.: Methods: For 299 patients ...

    Abstract Purpose: To study the role of the neutrophil:lymphocyte ratio (NLR) and monocyte:lymphocyte ratio (MLR) in discriminating between different patient groups hospitalized for fever due to infection and those without infection.
    Methods: For 299 patients admitted to hospital for fever with unknown cause, a number of characteristics including NLR and MLR were recorded. These characteristics were used in a multiple multinomial regression analysis to estimate the probability of a final diagnostic group of bacterial, viral, clinically confirmed, or no infection.
    Results: Both NLR and MLR significantly predicted final diagnostic group. Being highly correlated, however, both variables could not be retained in the same model. Both variables also interacted significantly with duration of fever. Generally, higher values of NLR and MLR indicated larger probabilities for bacterial infection and low probabilities for viral infection. Patients with septicemia had significantly higher NLR compared to patients with other bacterial infections with fever for less than one week. White blood cell counts, neutrophil counts, and C-reactive proteins did not differ significantly between septicemia and the other bacterial infection groups.
    Conclusions: NLR is a more useful diagnostic tool to identify patients with septicemia than other more commonly used diagnostic blood tests. NLR and MLR may be useful in the diagnosis of bacterial infection among patients hospitalized for fever.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Bacterial Infections/diagnosis ; Bacterial Infections/immunology ; Female ; Fever/epidemiology ; Fever/etiology ; Fever/microbiology ; Hospitalization ; Hospitals, University ; Humans ; Leukocyte Count ; Lymphocytes/immunology ; Male ; Middle Aged ; Monocytes/immunology ; Multivariate Analysis ; Neutrophils/immunology ; Norway/epidemiology ; Virus Diseases/diagnosis ; Virus Diseases/immunology ; Young Adult
    Language English
    Publishing date 2016-12-19
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 185104-4
    ISSN 1439-0973 ; 0300-8126 ; 0173-2129
    ISSN (online) 1439-0973
    ISSN 0300-8126 ; 0173-2129
    DOI 10.1007/s15010-016-0972-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Infective endocarditis in Western Norway: a 20-year retrospective survey.

    Jordal, Stina / Kittang, Bård Reiakvam / Salminen, Pirjo-Riitta / Eide, Geir Egil / Kommedal, Øyvind / Wendelbo, Øystein / Haaverstad, Rune / Sjursen, Haakon

    Infectious diseases (London, England)

    2018  Volume 50, Issue 10, Page(s) 757–763

    Abstract: Background: To investigate epidemiological trends of infective endocarditis (IE) in western Norway a retrospective study was performed.: Methods: Characteristics of 706 IE admissions from 1996 to 2005 and 2006 to 2015 were analysed and compared using ...

    Abstract Background: To investigate epidemiological trends of infective endocarditis (IE) in western Norway a retrospective study was performed.
    Methods: Characteristics of 706 IE admissions from 1996 to 2005 and 2006 to 2015 were analysed and compared using the Chi-square test for categorical variables and the t-test for age. Survival was analysed by multiple Cox regression and reported by the hazard ratio (HR).
    Results: Mean annual incidence rates increased from 4.6 to 7.4 per 100,000 inhabitants (rate ratio: 1.97, 95% confidence interval: 1.52-2.56, p < .001). Non-viridans streptococci, enterococci and Staphylococcus aureus (S. aureus), were all independently associated with increased mortality. The frequency of IE caused by enterococci increased from 3.7 to 13.0% (p < .001). The proportion of intravenous drug users (IVDU) increased from 16.5 to 23.5% (p = .015) and had increasing aortic valve involvement (p = .023). Prosthetic valve endocarditis (PVE) constituted 30% of IE cases in both decades with biological PVE increasing from 9.4 to 22.1% (p < .001) and mechanical PVE decreasing from 18.7 to 8.9% (p < .001). In the last decade, valve replacement surgery was performed in 37.6% of the patients, of which 85.5% received a bioprosthesis.
    Conclusions: The incidence of IE increased significantly. Non-viridans streptococci, enterococci and S. aureus were all significantly associated with increased mortality. The increased number of enterococcal IE and the increased number of IVDUs with left-sided IE constituted new challenges. Biological implants were preferred in a majority of patients requiring surgery.
    MeSH term(s) Adult ; Aged ; Endocarditis, Bacterial/epidemiology ; Endocarditis, Bacterial/mortality ; Enterococcus/isolation & purification ; Female ; Hospital Mortality ; Humans ; Incidence ; Male ; Middle Aged ; Norway/epidemiology ; Proportional Hazards Models ; Prosthesis-Related Infections/epidemiology ; Prosthesis-Related Infections/microbiology ; Retrospective Studies ; Risk Factors ; Staphylococcal Infections/epidemiology ; Streptococcal Infections/epidemiology ; Streptococcus/isolation & purification ; Substance Abuse, Intravenous/complications ; Surveys and Questionnaires
    Language English
    Publishing date 2018-06-19
    Publishing country England
    Document type Journal Article
    ZDB-ID 2839775-7
    ISSN 2374-4243 ; 2374-4235
    ISSN (online) 2374-4243
    ISSN 2374-4235
    DOI 10.1080/23744235.2018.1482419
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for

    Jacobsen, Henning / Rajendran, Madhusudan / Choi, Angela / Sjursen, Haakon / Brokstad, Karl A / Cox, Rebecca J / Palese, Peter / Krammer, Florian / Nachbagauer, Raffael

    mBio

    2017  Volume 8, Issue 5

    Abstract: The immunogenicity of current influenza virus vaccines is assessed by measuring an increase of influenza virus-specific antibodies in a hemagglutination inhibition assay. This method exclusively measures antibodies against the hemagglutinin head domain. ... ...

    Abstract The immunogenicity of current influenza virus vaccines is assessed by measuring an increase of influenza virus-specific antibodies in a hemagglutination inhibition assay. This method exclusively measures antibodies against the hemagglutinin head domain. While this domain is immunodominant, it has been shown that hemagglutination inhibition titers do not always accurately predict protection from disease. In addition, several novel influenza virus vaccines that are currently under development do not target the hemagglutinin head domain, but rather more conserved sites, including the hemagglutinin stalk. Importantly, antibodies against the hemagglutinin stalk do not show activity in hemagglutination inhibition assays and will require different methods for quantification. In this study, we tested human serum samples from a seasonal influenza virus vaccination trial and an avian H5N1 virus vaccination trial for antibody activities in multiple types of assays, including binding assays and also functional assays. We then performed serum transfer experiments in mice which then received an H1N1 virus challenge to assess the
    MeSH term(s) Adult ; Animals ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Antibody-Dependent Cell Cytotoxicity ; Biomarkers ; Clinical Trials as Topic ; Cross Reactions ; Disease Models, Animal ; Enzyme-Linked Immunosorbent Assay ; Female ; Hemagglutination Inhibition Tests ; Hemagglutinin Glycoproteins, Influenza Virus/chemistry ; Hemagglutinin Glycoproteins, Influenza Virus/immunology ; Humans ; Immunization, Passive ; Immunogenicity, Vaccine ; Influenza A Virus, H1N1 Subtype/immunology ; Influenza A Virus, H5N1 Subtype/immunology ; Influenza Vaccines/administration & dosage ; Influenza Vaccines/immunology ; Influenza, Human/immunology ; Influenza, Human/prevention & control ; Male ; Mice ; Middle Aged ; Orthomyxoviridae Infections/immunology ; Orthomyxoviridae Infections/prevention & control ; Orthomyxoviridae Infections/virology ; Vaccination
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Viral ; Biomarkers ; Hemagglutinin Glycoproteins, Influenza Virus ; Influenza Vaccines
    Language English
    Publishing date 2017-09-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2557172-2
    ISSN 2150-7511 ; 2161-2129
    ISSN (online) 2150-7511
    ISSN 2161-2129
    DOI 10.1128/mBio.01463-17
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Aminoglykosider bør fortsatt brukes i empirisk sepsisbehandling.

    Lindemann, Paul Christoffer / Haldorsen, Bjørg C / Smith, Ingrid / Sjursen, Haakon / Mylvaganam, Haima

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

    2013  Volume 133, Issue 10, Page(s) 1054–1055

    Title translation Aminoglycosides should still be used in empirical sepsis treatment.
    MeSH term(s) Aminoglycosides/adverse effects ; Aminoglycosides/therapeutic use ; Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/therapeutic use ; Drug Resistance, Bacterial ; Humans ; Sepsis/drug therapy
    Chemical Substances Aminoglycosides ; Anti-Bacterial Agents
    Language Norwegian
    Publishing date 2013-05-28
    Publishing country Norway
    Document type Journal Article
    ZDB-ID 603504-8
    ISSN 0807-7096 ; 0029-2001
    ISSN (online) 0807-7096
    ISSN 0029-2001
    DOI 10.4045/tidsskr.13.0213
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top